The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination
Abstract
Active multiple sclerosis lesions show inflammatory changes suggestive of a combined attack by autoreactive T and B lymphocytes against brain white matter. These pathogenic immune cells derive from progenitors that are normal, innocuous components of the healthy immune repertoire but become autoaggressive upon pathological activation. The stimuli triggering this autoimmune conversion have been commonly attributed to environmental factors, in particular microbial infection. However, using the relapsing-remitting mouse model of spontaneously developing experimental autoimmune encephalomyelitis, here we show that the commensal gut flora-in the absence of pathogenic agents-is essential in triggering immune processes, leading to a relapsing-remitting autoimmune disease driven by myelin-specific CD4(+) T cells. We show further that recruitment and activation of autoantibody-producing B cells from the endogenous immune repertoire depends on availability of the target autoantigen, myelin oligodendrocyte glycoprotein (MOG), and commensal microbiota. Our observations identify a sequence of events triggering organ-specific autoimmune disease and these processes may offer novel therapeutic targets.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similar to psoriasis, IL-17 pathway inhibitors (secukinumab and ixekizumab) have been shown to be effective in the treatment of PsA [141, 142].”
From TH17 cell heterogeneity and its role in tissue inflammation (2023) · cites this paper as [142]
In the citing paper
“in a laboratory model of multiple sclerosis, mice sensitized to the autoantigen, myelin oligodendrocyte glycoprotein, only developed experimental autoimmune encephalitis in the presence of commensal bacteria.45”
From The Gut Microbiome and the Brain (2014) · cites this paper as [45]
Citations
Cites
Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria
Ivanov, I. I., Atarashi, K., Manel, N., Brodie, E. L., Shima, T., Karaoz, U., Wei, D., Goldfarb, K. C., Santee, C. A., Lynch, S. V., et al. (2009) · Cell · doi:10.1016/j.cell.2009.09.033 · Cited by 4,554
Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species
Atarashi, K., Tanoue, T., Shima, T., Imaoka, A., Kuwahara, T., Momose, Y., Cheng, G., Yamasaki, S., Saito, T., Ohba, Y., et al. (2011) · Science · doi:10.1126/science.1198469 · Cited by 3,752
Kaser, A., Zeissig, S., & Blumberg, R. S. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101225 · Cited by 1,806
Ivanov, I. I., Frutos, R. D. L., Manel, N., Yoshinaga, K., Rifkin, D. B., Sartor, R. B., Finlay, B. B., & Littman, D. R. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.09.009 · Cited by 1,770
Gaboriau-Routhiau, V., Rakotobe, S., Lécuyer, E., Mulder, I., Lan, A., Bridonneau, C., Rochet, V., Pisi, A., De Paepe, M., Brandi, G., et al. (2009) · Immunity · doi:10.1016/j.immuni.2009.08.020 · Cited by 1,452
Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis
Lee, Y. K., Menezes, J. S., Umesaki, Y., & Mazmanian, S. K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000082107 · Cited by 1,323
Environmental risk factors for multiple sclerosis. Part I: The role of infection
Ascherio, A., & Munger, K. L. (2007) · Annals of Neurology · doi:10.1002/ana.21117 · Cited by 1,036
Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis
McMahon, E. J., Bailey, S. L., Castenada, C. V., Waldner, H., & Miller, S. D. (2005) · Nature Medicine · doi:10.1038/nm1202 · Cited by 694
Goverman, J. M., Woods, A., Larson, L., Weiner, L. P., Hood, L., & Zaller, D. M. (1993) · Cell · doi:10.1016/0092-8674(93)90074-z · Cited by 684
Intestinal Bacteria and the Regulation of Immune Cell Homeostasis
Hill, D. A., & Artis, D. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101330 · Cited by 600
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 1,000
Investigation of probiotics in multiple sclerosis
Tankou, S. K., Regev, K., Healy, B. C., Cox, L. M., Tjon, E., Kivisakk, P., Vanande, I. P., Cook, S., Gandhi, R., Glanz, B., et al. (2018) · Multiple Sclerosis Journal · doi:10.1177/1352458517737390 · Cited by 156
Ben‐Nun, A., Kaushansky, N., Kawakami, N., Krishnamoorthy, G., Berer, K., Liblau, R., Hohlfeld, R., & Wekerle, H. (2014) · Journal of Autoimmunity · doi:10.1016/j.jaut.2014.06.004 · Cited by 165
Self-citationDiet, Gut Microbiota, and Vitamins D + A in Multiple Sclerosis
Riccio, P., & Rossano, R. (2017) · Neurotherapeutics · doi:10.1007/s13311-017-0581-4 · Cited by 164
Intestinal microbiota: Shaping local and systemic immune responses
Molloy, M. J., Bouladoux, N. J., & Belkaid, Y. (2011) · Seminars in Immunology · doi:10.1016/j.smim.2011.11.008 · Cited by 159
The fecal microbiome of ALS patients
Brenner, D., Hiergeist, A., Adis, C. I., Mayer, B., Gessner, A., Ludolph, A. C., & Weishaupt, J. H. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.09.023 · Cited by 156
The aryl hydrocarbon receptor and the gut–brain axis
Barroso, A., Mahler, J. V., Fonseca-Castro, P. H., & Quintana, F. J. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-00585-5 · Cited by 152
Environmental factors in autoimmune diseases and their role in multiple sclerosis
Haase, S., Grohme, D. A., Erzler, M., Binsfeld, M., Haghikia, A., Müller, D. N., Linker, R. A., & Kleinewietfeld, M. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2311-1 · Cited by 156
Schizophrenia and the gut–brain axis
Nemani, K., Hosseini Ghomi, R., McCormick, B., & Fan, X. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2014.08.018 · Cited by 151
Epigenetic mechanisms in multiple sclerosis: implications for pathogenesis and treatment
Huynh, J. L., & Casaccia, P. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70309-5 · Cited by 162
Gut microbiota in renal physiology: focus on short-chain fatty acids and their receptors
Pluznick, J. L. (2016) · Kidney International · doi:10.1016/j.kint.2016.06.033 · Cited by 153
Cheng, S., Ma, X., Geng, S., Jiang, X., Li, Y., Hu, L., Lǐ, J., Wang, Y., & Han, X. (2018) · mSystems · doi:10.1128/msystems.00137-18 · Cited by 153
Microbial view of central nervous system autoimmunity
Berer, K., & Krishnamoorthy, G. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.04.007 · Cited by 153
Self-citationSécher, T., Kassem, S., Benamar, M., Bernard, I., Boury, M., Barreau, F., Oswald, É., & Saoudi, A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01096 · Cited by 148
Cross talk between neutrophils and the microbiota
Zhang, D., & Frenette, P. S. (2019) · Blood · doi:10.1182/blood-2018-11-844555 · Cited by 153
Buscarinu, M. C., Cerasoli, B., Annibali, V., Policano, C., Lionetto, L., Capi, M., Mechelli, R., Romano, S., Fornasiero, A., Mattei, G., et al. (2016) · Multiple Sclerosis Journal · doi:10.1177/1352458516652498 · Cited by 149
Microbiota and neurologic diseases: potential effects of probiotics
Umbrello, G., & Esposito, S. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-1058-7 · Cited by 147
Dolpady, J., Sorini, C., Pietro, C. D., Cosorich, I., Ferrarese, R., Saita, D., Clementi, M., Canducci, F., & Falcone, M. (2015) · Journal of Diabetes Research · doi:10.1155/2016/7569431 · Cited by 147
Al-Ghezi, Z. Z., Busbee, P. B., Alghetaa, H., Nagarkatti, P. S., & Nagarkatti, M. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.07.028 · Cited by 149
Diet, gut microbiota and cognition
Proctor, C., Thiennimitr, P., Chattipakorn, N., & Chattipakorn, S. C. (2017) · Metabolic Brain Disease · doi:10.1007/s11011-016-9917-8 · Cited by 144
Fecal microbiota transplantation associated with 10 years of stability in a patient with SPMS
Makkawi, S., Camara-Lemarroy, C. R., & Metz, L. M. (2018) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000459 · Cited by 144
Calderón‐Garcidueñas, L., Vojdani, A., Blaurock-Busch, E., Busch, Y. M., Friedle, A., Franco-Lira, M., Mukherjee, P. S., Martínez-Aguirre, X., Park, S., Torres‐Jardón, R., et al. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-141365 · Cited by 148
Amato, M. P., Derfuss, T. J., Hemmer, B., Liblau, R., Montalbán, X., Sørensen, P. S., Miller, D. H., For the 2016 ECTRIMS Focused Workshop Group, Alfredsson, L. S., Aloisi, F., et al. (2017) · Multiple Sclerosis Journal · doi:10.1177/1352458516686847 · Cited by 152
Self-citationSLE: Another Autoimmune Disorder Influenced by Microbes and Diet?
Mu, Q., Zhang, H., & Luo, X. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00608 · Cited by 147
Connection between gut microbiome and brain development in preterm infants
Lu, J. N., & Claud, E. C. (2018) · Developmental Psychobiology · doi:10.1002/dev.21806 · Cited by 152
A clinical update on the significance of the gut microbiota in systemic autoimmunity
Rosser, E. C., & Mauri, C. (2016) · Journal of Autoimmunity · doi:10.1016/j.jaut.2016.06.009 · Cited by 142
The Gut Microbiome and Multiple SclerosisPreprint
Ochoa‐Repáraz, J., Kirby, T. O., & Kasper, L. H. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a029017 · Cited by 143
Clostridium Difficile Infection
Lübbert, C., John, E., & von Müller, L. (2014) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2014.0723 · Cited by 147
Schirbel, A., Kessler, S. P., Rieder, F., West, G. A., Rebert, N. A., Asosingh, K., McDonald, C., & Fiocchi, C. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.11.005 · Cited by 142
Ferolla, S. M., Couto, C. A., Costa‐Silva, L., Armiliato, G. N. D. A., Pereira, C., Martins, F. S., Ferrari, M. L., Vilela, E. G., Tôrres, H. O. D. G., da Cunha, A. S., et al. (2016) · Nutrients · doi:10.3390/nu8070397 · Cited by 136
The microbiota and autoimmunity: Their role in thyroid autoimmune diseases
Köhling, H.-L., Plummer, S. F., Marchesi, J. R., Davidge, K. S., & Ludgate, M. (2017) · Clinical Immunology · doi:10.1016/j.clim.2017.07.001 · Cited by 139
Animal models of multiple sclerosis: From rodents to zebrafish
Burrows, D. J., McGown, A., Jain, S. A., De Felice, M., Ramesh, T. M., Sharrack, B., & Majid, A. (2019) · Multiple Sclerosis Journal · doi:10.1177/1352458518805246 · Cited by 135
Lymphotoxin signalling in immune homeostasis and the control of microorganisms
Upadhyay, V., & Fu, Y. (2013) · Nature reviews. Immunology · doi:10.1038/nri3406 · Cited by 136
Brain-Reactive Antibodies and Disease
Diamond, B., Honig, G., Mader, S., Brimberg, L., & Volpe, B. T. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-075041 · Cited by 138
The Second Brain: Is the Gut Microbiota a Link Between Obesity and Central Nervous System Disorders?
Ochoa‐Repáraz, J., & Kasper, L. H. (2016) · Current Obesity Reports · doi:10.1007/s13679-016-0191-1 · Cited by 141
The role of gut microbiota in T cell immunity and immune mediated disorders
Shim, J. A., Ryu, J. H., Jo, Y., & Hong, C. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.79430 · Cited by 140
Cassani, L., Gomez-Zavaglia, A., & Simal-Gandara, J. (2020) · Food Research International · doi:10.1016/j.foodres.2019.108852 · Cited by 133
Luchtman, D. W., Ellwardt, E., Larochelle, C., & Zipp, F. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.07.013 · Cited by 137
Xiong, W., Abraham, P. E., Li, Z., Pan, C., & Hettich, R. L. (2015) · PROTEOMICS · doi:10.1002/pmic.201400571 · Cited by 136
Koutrolos, M., Berer, K., Kawakami, N., Wekerle, H., & Krishnamoorthy, G. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0163-1 · Cited by 139
Self-citationRegulatory T Cells and Immune Tolerance in the IntestinePreprint
Harrison, O. B., & Powrie, F. M. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a018341 · Cited by 137
Gut Microbiome and Multiple Sclerosis
Bhargava, P., & Mowry, E. M. (2014) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-014-0492-2 · Cited by 129
Functional Two-Way Crosstalk Between Brain and Lung: The Brain–Lung Axis
Li, C., Chen, W., Lin, F., Li, W., Wang, P., Liao, G., & Zhang, L. (2022) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-022-01238-z · Cited by 129
The Gut-Microglia Connection: Implications for Central Nervous System Diseases
Wang, Y., Wang, Z., Wang, Y., Li, F., Jia, J., Song, X., Qin, S., Wang, R., Jin, F., Kitazato, K., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02325 · Cited by 130
Microbiome and immunological interactions
Kelly, D., & Mulder, I. E. (2012) · Nutrition Reviews · doi:10.1111/j.1753-4887.2012.00498.x · Cited by 131
The role of short-chain fatty acid on blood pressure regulation
Miyamoto, J., Kasubuchi, M., Nakajima, A., Irie, J., Itoh, H., & Kimura, I. (2016) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000246 · Cited by 128
Myasthenia Gravis: Paradox versus paradigm in autoimmunity
Berrih‐Aknin, S. (2014) · Journal of Autoimmunity · doi:10.1016/j.jaut.2014.05.001 · Cited by 129
Infection as an Environmental Trigger of Multiple Sclerosis Disease Exacerbation
Steelman, A. J. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00520 · Cited by 131
Functional immune cell–astrocyte interactions
Sanmarco, L. M., Polonio, C. M., Wheeler, M. A., & Quintana, F. J. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20202715 · Cited by 134
Marietta, E. V., Gomez, A. M., Yeoman, C. J., Tilahun, A. Y., Clark, C. R., Luckey, D. H., Murray, J. A., White, B. A., Kudva, Y. C., & Rajagopalan, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078687 · Cited by 125
Gut Microbiota Are Disease-Modifying Factors After Traumatic Spinal Cord Injury
Kigerl, K. A., Mostacada, K., & Popovich, P. G. (2017) · Neurotherapeutics · doi:10.1007/s13311-017-0583-2 · Cited by 126
Age-related changes in intestinal immunity and the microbiome
Walrath, T., Dyamenahalli, K. U., Hulsebus, H. J., McCullough, R. L., Idrovo, J., Boe, D. M., McMahan, R. H., & Kovacs, E. J. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.3ri0620-405rr · Cited by 129
The gut microbiota in multiple sclerosis varies with disease activity
Thirion, F., Sellebjerg, F. T., Fan, Y., Lyu, L., Hansen, T. H., Pons, N., Levenez, F., Quinquis, B., Stankevič, E., Søndergaard, H. B., et al. (2023) · Genome Medicine · doi:10.1186/s13073-022-01148-1 · Cited by 133
The Gut-Brain Axis in Inflammatory Bowel Disease—Current and Future Perspectives
Günther, C., Rothhammer, V., Karow, M., Neurath, M., & Winner, B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168870 · Cited by 123
Autoimmune host–microbiota interactions at barrier sites and beyond
Ruff, W. E., & Kriegel, M. A. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.02.006 · Cited by 122
Short-chain fatty acids and gut microbiota in multiple sclerosis
Melbye, P., Olsson, A., Hansen, T. H., Søndergaard, H. B., & Oturai, A. B. (2018) · Acta Neurologica Scandinavica · doi:10.1111/ane.13045 · Cited by 125
Gut microbiota–driven brain Aβ amyloidosis in mice requires microglia
Dodiya, H. B., Lutz, H. L., Weigle, I. Q., Patel, P., Michalkiewicz, J., Roman-Santiago, C. J., Zhang, C. M., Liang, Y., Srinath, A., Zhang, X., et al. (2022) · Journal of Experimental Medicine · doi:10.1084/jem.20200895 · Cited by 120
Toward Effective Probiotics for Autism and Other Neurodevelopmental Disorders
Gilbert, J. A., Krajmalnik‐Brown, R., Porazinska, D. L., Weiss, S. J., & Knight, R. D. (2013) · Cell · doi:10.1016/j.cell.2013.11.035 · Cited by 124
Innately versatile: γδ17 T cells in inflammatory and autoimmune diseases
Papotto, P. H., Reinhardt, A., Prinz, I., & Silva‐Santos, B. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.11.006 · Cited by 123
Gong, H., Zhang, S., Li, Q., Zuo, C., Gao, X., Zheng, B., & Lin, M. (2020) · Experimental Eye Research · doi:10.1016/j.exer.2020.107921 · Cited by 121
Microglia in neurodegenerative diseases
Xu, Y., Jin, M.-Z., Yang, Z., & Jin, M.-Z. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.290881 · Cited by 121
Gut microbiome-mediated regulation of neuroinflammation
Bostick, J. W., Schonhoff, A. M., & Mazmanian, S. K. (2022) · Current Opinion in Immunology · doi:10.1016/j.coi.2022.102177 · Cited by 120
Multiple Sclerosis Risk Factors and Pathogenesis
Nourbakhsh, B., & Mowry, E. M. (2019) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000725 · Cited by 126
Psychological Stress, Intestinal Barrier Dysfunctions, and Autoimmune Disorders: An Overview
Ilchmann-Diounou, H., & Ménard, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01823 · Cited by 125
Riedhammer, C., & Weissert, R. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00322 · Cited by 124
The immune system and stroke: from current targets to future therapy
Malone, K., Amu, S., Moore, A., & Waeber, C. (2018) · Immunology and Cell Biology · doi:10.1111/imcb.12191 · Cited by 116
Gut feelings about smoking and coffee in Parkinson's disease
Derkinderen, P., Shannon, K. M., & Brundin, P. (2014) · Movement Disorders · doi:10.1002/mds.25882 · Cited by 115
Ultrahigh-throughput functional profiling of microbiota communities
Terekhov, S. S., Smirnov, I. V., Malakhova, M. V., Samoilov, A. E., Manolov, A. I., Nazarov, A. S., Danilov, D. V., Dubiley, S. A., Osterman, I. А., Rubtsova, M. P., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1811250115 · Cited by 115
Tremlett, H. L., Fadrosh, D. W., Faruqi, A. A., Hart, J., Roalstad, S., Graves, J., Spencer, C. M., Lynch, S. V., Zamvil, S. S., & Waubant, E. L. (2016) · BMC Neurology · doi:10.1186/s12883-016-0703-3 · Cited by 117
IFN‐γ promotes transendothelial migration of CD4+ T cells across the blood–brain barrier
Sonar, S. A., Shaikh, S., Joshi, N., Atre, A. N., & Lal, G. (2017) · Immunology and Cell Biology · doi:10.1038/icb.2017.56 · Cited by 121
Much More Than IL-17A: Cytokines of the IL-17 Family Between Microbiota and Cancer
Brevi, A., Cogrossi, L. L., Grazia, G., Masciovecchio, D., Impellizzieri, D., Lacanfora, L., Grioni, M., & Bellone, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.565470 · Cited by 114
Nrf2/ARE Pathway Modulation by Dietary Energy Regulation in Neurological Disorders
Vasconcelos, A. R., dos Santos, N. B., Scavone, C., & Munhoz, C. D. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00033 · Cited by 113
Effects of gut microbiota on the microRNA and mRNA expression in the hippocampus of mice
Chen, J.-J., Zeng, B.-H., Li, W.-W., Zhou, C.-J., Fan, S.-H., Cheng, K., Zeng, L., Zheng, P., Fang, L., Wei, H., et al. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.01.021 · Cited by 111
IL-17 controls central nervous system autoimmunity through the intestinal microbiome
Regen, T., Isaac, S., Amorim, A., Núñez, N. G., Hauptmann, J., Shanmugavadivu, A., Klein, M., Sankowski, R., Mufazalov, I. A., Yogev, N., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.aaz6563 · Cited by 111
Pröbstel, A.-K., & Baranzini, S. E. (2018) · Neurotherapeutics · doi:10.1007/s13311-017-0587-y · Cited by 110
Zhu, C. S., Grandhi, R., Patterson, T. F., & Nicholson, S. E. (2018) · Brain Sciences · doi:10.3390/brainsci8060113 · Cited by 112
Xu, J., Moore, B. N., & Pluznick, J. L. (2022) · Hypertension · doi:10.1161/hypertensionaha.122.18558 · Cited by 119
Praveenraj, S. S., Sonali, S., Anand, N., Hediyal, T. A., Vichitra, C., Kalyan, M., Kanna, P. V., Chandana, K. A., Paneyala, S., Mahalakshmi, A. M., et al. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02990-5 · Cited by 116
Li, L., Rao, S., Cheng, Y., Zhuo, X., Deng, C., Xu, N., Zhang, H., & Yang, L. (2019) · MicrobiologyOpen · doi:10.1002/mbo3.810 · Cited by 109
“Furthermore, the induction effect of intestinal microbiota on systemic Th17 and Treg cells was also confirmed (Atarashi et al., 2011; Berer et al., 2011; Yun & Gordon, 2011).”
BackgroundRole of Gut Microbiota in Obesity, Type 2 Diabetes and Alzheimer’s Disease
Naseer, M. I., Bibi, F., Al-Qahtani, M. H., Chaudhary, A., Azhar, E. I., Kamal, M. A., & Yasir, M. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/18715273113126660147 · Cited by 109
Invited Review: From nose to gut – the role of the microbiome in neurological disease
Bell, J. S., Spencer, J. I., Yates, R. L., Yee, S. A., Jacobs, B. M., & DeLuca, G. C. (2018) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12520 · Cited by 111
The Gut Microbiome as Therapeutic Target in Central Nervous System Diseases: Implications for Stroke
Winek, K., Dirnagl, U., & Meisel, A. (2016) · Neurotherapeutics · doi:10.1007/s13311-016-0475-x · Cited by 108
Wekerle, H. (2017) · Autoimmunity · doi:10.1080/08916934.2017.1281914 · Cited by 108
Self-citationGut immune cell trafficking: inter-organ communication and immune-mediated inflammation
Zundler, S., Günther, C., Kremer, A. E., Zaiss, M. M., Rothhammer, V., & Neurath, M. F. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00663-1 · Cited by 112
Brown, J. M., & Hazen, S. L. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.r116.765388 · Cited by 108
Seo, D.-O., & Holtzman, D. M. (2019) · The Journals of Gerontology Series A · doi:10.1093/gerona/glz262 · Cited by 109
Microbiota-brain interactions: Moving toward mechanisms in model organisms
Nagpal, J. K., & Cryan, J. F. (2021) · Neuron · doi:10.1016/j.neuron.2021.09.036 · Cited by 110
Disease-modifying therapies alter gut microbial composition in MS
Sand, I. K., Zhu, Y., Ntranos, A., Clemente, J. C., Cekanaviciute, E., Brandstadter, R., Crabtree‐Hartman, E., Singh, S., Bencosme, Y., Debelius, J. W., et al. (2018) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000517 · Cited by 106
Gut Microbiota Interaction with the Central Nervous System throughout Life
Ojeda, J., Ávila, A., & Vidal, P. M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10061299 · Cited by 112
Apoptosis in response to microbial infection induces autoreactive TH17 cells
Campisi, L., Barbet, G., Ding, Y., Esplugues, E., Flavell, R. A., & Blander, J. M. (2016) · Nature Immunology · doi:10.1038/ni.3512 · Cited by 105
The Gut Microbiome in Multiple Sclerosis: A Potential Therapeutic Avenue
Kirby, T. O., & Ochoa‐Repáraz, J. (2018) · Medical Sciences · doi:10.3390/medsci6030069 · Cited by 114
Ding, W., You, Z., Chen, Q., Yang, L., Doheny, J. T., Zhou, X. P., Li, N., Wang, S., Hu, K., Chen, L. L., et al. (2020) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000005155 · Cited by 105
Parodi, B., & de Rosbo, N. K. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.718220 · Cited by 114
Role of Akkermansia in Human Diseases: From Causation to Therapeutic Properties
Pellegrino, A., Coppola, G., Santopaolo, F., Gasbarrini, A., & Ponziani, F. R. (2023) · Nutrients · doi:10.3390/nu15081815 · Cited by 107
Dysregulation of immune homeostasis in autoimmune diseases
Kuchroo, V. K., Ohashi, P. S., Sartor, R. B., & Vinuesa, C. G. (2012) · Nature Medicine · doi:10.1038/nm.2621 · Cited by 105
Brain microbiota disruption within inflammatory demyelinating lesions in multiple sclerosis
Branton, W. G., Lu, J., Surette, M. G., Holt, R. A., Lind, J. C., Laman, J. D., & Power, C. (2016) · Scientific Reports · doi:10.1038/srep37344 · Cited by 104
Clinical Effect of IRT-5 Probiotics on Immune Modulation of Autoimmunity or Alloimmunity in the Eye
Kim, J., Choi, S. H., Kim, Y., Jeong, H. J., Ryu, J. J., Lee, H. J., Kim, T., Im, S., Oh, J. Y., & Kim, M. (2017) · Nutrients · doi:10.3390/nu9111166 · Cited by 104
Gut microbiome of treatment-naïve MS patients of different ethnicities early in disease course
Ventura, R. E., Iizumi, T., Battaglia, T., Liu, M., Perez-Perez, G. I., Herbert, J., & Blaser, M. J. (2019) · Scientific Reports · doi:10.1038/s41598-019-52894-z · Cited by 106
Gut Microbiota Dysbiosis Induced by Intracerebral Hemorrhage Aggravates Neuroinflammation in Mice
Yu, X., Zhou, G., Shao, B., Zhou, H., Xu, C., Yan, F., Wang, L., Chen, G., Li, J., & Fu, X. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.647304 · Cited by 104
The Gut Microbiome in Multiple Sclerosis
Mielcarz, D. W., & Kasper, L. H. (2015) · Current Treatment Options in Neurology · doi:10.1007/s11940-015-0344-7 · Cited by 109
Duc, D., Vigne, S., Bernier‐Latmani, J., Yersin, Y., Ruiz, F., Gaïa, N., Léo, S., Lazarević, V., Schrenzel, J., Petrova, T. V., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.09.002 · Cited by 110
Metadata
- Authors
- Berer, K., Mues, M., Koutrolos, M., Rasbi, Z. A., Boziki, M., Johner, C., Wekerle, H., & Krishnamoorthy, G.
- Affiliations
- Max Planck Institute of Neurobiology (DE)
- Max Planck Society (DE)
- Corresponding author
- Wekerle, Hartmut
- Krishnamoorthy, Gurumoorthy
- Venue
- Nature
- Published
- 2011-10-26
- Volume
- 479
- Issue
- 7374
- Pages
- 538-541
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2037907937
- Cited by
- 1,251
- References
- 29
- Citations by year
- 2026: 34 · 2025: 45 · 2024: 74 · 2023: 78 · 2022: 107 · 2021: 101 · 2020: 100 · 2019: 93 · 2018: 110 · 2017: 105 · 2016: 113 · 2015: 87 · 2014: 74 · 2013: 72 · 2012: 47
- FWCI
- 44.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Max Planck Digital Library (submittedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- Funders
- Division of Materials Research
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- commensal gut microbiota, myelin autoantigens, myelin oligodendrocyte glycoprotein, multiple sclerosis, experimental autoimmune encephalomyelitis, autoimmune demyelination, autoantibody-producing B cells, CD4+ T cells, diet and microbiome, relapsing-remitting multiple sclerosis
- MeSH terms
- Animals, Autoantigens, B-Lymphocytes, Brain, Cell Movement, Diet, Encephalomyelitis, Autoimmune, Experimental, Germ-Free Life, Lymph Nodes, Lymphocyte Activation, Myelin Proteins, Myelin Sheath, Stomach, T-Lymphocytes, Autoimmunity, Cytokines, Germinal Center, Adoptive Transfer, Multiple Sclerosis, Relapsing-Remitting, Mice, Metagenome, Myelin-Oligodendrocyte Glycoprotein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review